100
Participants
Start Date
January 21, 2025
Primary Completion Date
January 31, 2027
Study Completion Date
January 31, 2028
Observation only
Only observation following standard of care (histological diagnosis, molecular classification, progestine therapy)
RECRUITING
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
OTHER